University of Minnesota. Driven to Discover.
Broad-spectrum antibiotics didn't produce better clinical or patient-centered results.
The FDA bans the marketing of OTC antiseptics containing triclosan and 23 other active antimicrobial agents.
Researchers are relieved to resume experiments, but some public health questions remain.
Only 19 states reported increasing or maintaining their public health budgets, down from 26 last year.
"Censorship . . . threatens to disrupt a prime goal of government: protecting public safety," the groups write.
A phase 3 trial shows ceftazidime-avibactam "non-inferior" to meropenem.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyAcademic Health Center, University of Minnesota, Minneapolis, MN
© 2018 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.